Not yet recruitingInterventionalNot ApplicableLast updated Aug 7, 2026

A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery

A Multicenter, Open-Label, Randomized Controlled Trial on the Efficacy and Safety of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery

Overview

ClinicalTrials.gov ID: NCT07751367
Lead Sponsor: Tianjin Medical University Cancer Institute and HospitalOTHER
Brief Summary: This study aims to investigate the efficacy and safety of high-dose Oryz-Aspergillus Enzyme And Pancreatin Tablet in treating postoperative pancreatic exocrine insufficiency (PEI), aiming to fill the gap in evidence-based medicine and promote standardized treatment.
Study Type

Status

Overall Status: Not yet recruiting
Start Date: Sep 18, 2026Estimated
Primary Completion Date: Jul 31, 2028Estimated
Completion Date: Dec 31, 2028Estimated

Study Record Dates

First Submitted: Jul 20, 2026
First Submitted that Met QC Criteria: Aug 6, 2026
First Posted: Aug 7, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 6, 2026
Last Update Posted: Aug 7, 2026Actual
Last Verified: Jul 2026

NCT04057326Unknown status

A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition

NCT05112328Unknown status

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding

NCT01430234Completed

Enzyme Suppletion in Exocrine Pancreatic Dysfunction

NCT07697352Not yet recruiting

Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis

NCT01401387Withdrawn

Pancreatic Enzyme Suppletion in Pancreatic Cancer

NCT07314489Recruiting

A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis